top of page
Actorius_logo
Contact

Events

|

30 August 2026

ISLB Annual Congress 2026 | 7-9 November | Madrid, Spain

Actorius will present seven scientific posters at ISLB 2026 in Madrid, showcasing research advancing the clinical potential of CTCs across treatment monitoring, biomarker analysis, residual disease, and metastasis research.

Seven studies. One shared goal: advancing the clinical potential of circulating tumor cells.


This November, at ISLB 2026 in Madrid, Actorius will present seven scientific posters at the International Society of Liquid Biopsy Congress—the highest number of accepted posters from any academic group or company.


Our team will be presenting research spanning CTC biology, treatment monitoring, biomarker expression, algorithm-based analysis, minimal cellular residual disease, and extracorporeal approaches.


Our Poster Presentations


  1. Comparative Analysis of Circulating Tumor Cells, Clusters, and PD-L1 Expression in Paired Peripheral and Portal Venous Blood with Solid Malignancies


  2. Detection of Androgen Receptor Splice Variant 7 in Circulating Tumor Cells for Dynamic Treatment Decision in Prostate Cancer Patients


  3. Algorithm-Based Analysis of Circulating Tumour Cells in Cancer Patients


  4. Evaluation of Circulating Tumor Cells Expressing PD-L1 and CTC Clusters at Baseline and Follow-Ups in Triple-Negative Breast Cancer


  5. Capture of Cancerous Cells and Overall Survival in Rats Using an Ex-Vivo Extracorporeal Device in Multiple Onco-Dialysis Cycles


  6. Capture of Epithelial-Mesenchymal Transitioning Circulating Tumor Cells Using an Affinity-Based N-Cadherin System


  7. Assessment of Minimal Cellular Residual Disease Using Circulating Tumour Cells in Pre- and Post-Surgery Breast Cancer Patients


Across these seven studies, one theme connects our work:

That is making circulating tumor cells more clinically meaningful—from understanding tumor biology and treatment response to monitoring residual disease and exploring new approaches to metastasis.



Meet our Founders


Our three co-founders will also be at ISLB Annual congress. If you work in liquid biopsy, CTC biology, oncology research, or precision oncology, we would be glad to connect and exchange perspectives.


Visit us at Booth 7


Meet us in Madrid, or book a meeting in advance





#ISLB2026 #LiquidBiopsy #CirculatingTumorCells #CTC #PrecisionOncology #CancerResearch #OncologyResearch #Actorius #CancerDiagnostics #Metastasis Research

Book appointment

Stay One Step
Ahead of Cancer.

Get the latest news and innovations from Actorius delivered straight to your inbox.

Subscribe for regular updates

bottom of page